NLI
DGX icon

Nippon Life Insurance’s Quest Diagnostics DGX Stock Holding History

Nippon Life Insurance’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,585
Closed -$1.37M – 102
2017
Q3 		$1.37M Buy
14,585
+455
+3% +$48.3K 0.03% 236
2017
Q2 		$1.57M Sell
14,130
-806
-5% -$85.2K 0.03% 188
2017
Q1 		$1.47M Buy
14,936
+3,575
+31% +$341K 0.03% 219
2016
Q4 		$1.04M Buy
+11,361
New +$979K 0.02% 287

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nippon Life Insurance's DGX Position: Q4 2017 in Review

Nippon Life Insurance sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 14,585 shares — an estimated $1.37M sold.

Nippon Life Insurance first reported a position in DGX in Q4 2016 and held it in 4 quarters. The position peaked at $1.57M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Nippon Life Insurance reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 14,585 Quest Diagnostics shares in Q4 2017, an estimated $1.37M.
  • Nippon Life Insurance first reported a position in Quest Diagnostics in Q4 2016 and held it in 4 quarters.
  • Nippon Life Insurance's Quest Diagnostics position peaked at $1.57M in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.